文献速递中毒与环境急症心脑血管急症重症综合管理与镇静镇痛

血尿素氮/白蛋白比值、中枢神经特异蛋白S100β与心肌肌钙蛋白I和中重度急性一氧化碳中毒病情严重程度及预后的相关性分析

[Correlation analysis of blood urea nitrogen/albumin ratio, central nervous system specific protein S100 and cardiac troponin I with severity assessment and prognosis in patients with moderate-to-severe acute carbon monoxide poisoning].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论中重度急性一氧化碳中毒患者入院时及第3天B/A比值、S100β、cTnI升高提示迟发性脑病风险增加,三者联合(尤其第3天)预测价值最高。

该回顾性队列纳入178例中重度急性一氧化碳中毒患者,按病情分为中度91例、重度87例,按60天随访是否发生迟发性脑病分为预后良好157例、预后不良21例。重度组入院时及第3天B/A比值、S100β、cTnI均高于中度组;预后不良组上述指标亦高于预后良好组。逐步logistic回归显示入院时及第3天B/A比值、S100β、cTnI升高均为迟发性脑病的危险因素。三者联合预测迟发性脑病的AUC入院时为0.872、第3天为0.904,第3天联合预测优于入院时及单独检测。

要点

  • 中重度急性一氧化碳中毒患者入院时及第3天B/A比值、S100β、cTnI升高与病情严重程度及迟发性脑病发生相关(均P<0.05)。
  • 入院时B/A比值(OR=1.272,95%CI 1.028-1.573)、S100β(OR=1.065,95%CI 1.007-1.127)、cTnI(OR=1.358,95%CI 1.055-1.748)升高为迟发性脑病危险因素。
  • 第3天B/A比值、S100β(OR=1.112,95%CI 1.060-1.165)、cTnI(OR=1.201,95%CI 1.008-1.432)升高亦为迟发性脑病危险因素。
  • 入院时三者联合预测迟发性脑病AUC 0.872(敏感度95.2%、特异度68.8%),第3天联合AUC 0.904(敏感度85.7%、特异度80.3%)。
  • 第3天三者联合预测优于入院时联合、中毒程度、昏迷时间及单独检测(均P<0.05)。

适用人群与场景

  • 2023年3月1日至2025年12月31日收治于Harrison International Peace Hospital的中重度急性一氧化碳中毒患者,共178例(中度91例、重度87例)。
  • 原文未提及排除人群及具体纳入标准细节。

诊断标准与关键阈值

  • 按病情严重程度分为中度中毒组和重度中毒组;按60天随访是否发生迟发性一氧化碳中毒性脑病(DEACMP)分为预后良好组和预后不良组。
  • B/A比值由血尿素氮(BUN)与白蛋白(Alb)计算;检测时间点为入院时及入院第3天。

处置流程与药物剂量

  • 原文未提及具体治疗药物、剂量、给药途径或处置流程。

红旗征与不能漏的情况

  • 中重度急性一氧化碳中毒患者入院时或第3天B/A比值、S100β、cTnI升高提示迟发性脑病风险增加,需早期筛查。
  • 昏迷时间延长、中毒至就诊时间延长、血糖、CRP、乳酸、BUN升高及Alb降低与病情严重及预后不良相关(均P<0.05)。

研究设计与关键结果

  • 研究类型:回顾性队列研究,单中心,样本量178例中重度急性一氧化碳中毒患者。
  • 重度组入院时脉搏及呼吸频率更快、昏迷时间及中毒至就诊时间更长,血糖、CRP、Lac、BUN更高,Alb更低(均P<0.05);入院时及第3天B/A比值、S100β、cTnI均高于中度组(均P<0.05)。
  • 中度组第3天较入院时B/A比值升高、cTnI下降(均P<0.05),S100β无显著变化;重度组第3天与入院时B/A比值、S100β、cTnI差异无统计学意义。
  • 预后不良组(21例)较预后良好组(157例)昏迷时间及中毒至就诊时间更长、重度中毒比例更高,血糖、CRP、Lac、BUN更高、Alb更低(均P<0.05);入院时及第3天B/A比值、S100β、cTnI均更高(均P<0.05)。
  • Pearson相关分析示入院时及第3天B/A比值、S100β、cTnI与病情严重程度及DEACMP发生相关(均P<0.05)。
  • 逐步logistic回归示入院时B/A比值OR=1.272(95%CI 1.028-1.573)、S100β OR=1.065(95%CI 1.007-1.127)、cTnI OR=1.358(95%CI 1.055-1.748);第3天B/A比值OR=1.170(95%CI 0.947-1.463)、S100β OR=1.112(95%CI 1.060-1.165)、cTnI OR=1.201(95%CI 1.008-1.432)。
  • ROC曲线:入院时三者联合预测DEACMP的AUC 0.872(敏感度95.2%、特异度68.8%),第3天联合AUC 0.904(敏感度85.7%、特异度80.3%);第3天联合预测优于入院时联合、中毒程度、昏迷时间及单独检测(均P<0.05)。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:单中心、回顾性设计、预后不良组样本量较小(21例),原文未提及盲法或外部验证。

对床旁实践的改变

  • 对中重度急性一氧化碳中毒患者,可在入院时及第3天检测B/A比值、S100β、cTnI,用于早期筛查迟发性脑病高风险人群;第3天三者联合预测价值最高。
  • 三者联合预测为风险分层工具,原文未提供用于决策的具体阈值,不能替代临床判断。
  • 原文未提及该策略对治疗决策或患者结局的影响,不改变具体治疗流程。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the correlation between blood urea nitrogen/albumin (B/A) ratio, central nervous system specific protein S100 (S100β), cardiac troponin I (cTnI) and the severity assessment and prognosis in patients with moderate-to-severe acute carbon monoxide poisoning (ACMP).

METHODS: A retrospective cohort study was performed, enrolling patients with moderate-to-severe ACMP admitted to the Harrison International Peace Hospital from March 1, 2023 to December 31, 2025 as the study subjects. Baseline clinical data at admission were recorded, including coma duration, time from poisoning to presentation, etc. Blood routine examination, electrolyte levels, liver function, blood glucose, C-reactive protein (CRP), blood lactic acid (Lac), blood urea nitrogen (BUN), albumin (Alb), cTnI, S100β, as well as BUN, Alb, cTnI, S100β at admission and 3 days after admission were collected, and the B/A ratio was calculated. Patients were followed up for 60 days to assess clinical prognosis. According to the severity of the patients' condition, they were stratified into the moderate poisoning group and the severe poisoning group; further, based on the occurrence of delayed carbon monoxide encephalopathy (DEACMP) during the 60-day follow-up, they were divided into the good prognosis group and the poor prognosis group. Pearson correlation analysis was used to explore the associations of B/A ratio, S100β, and cTnI with the severity of ACMP patients and the occurrence of DEACMP; stepwise logistic regression analysis was used to analyze the influencing factors of DEACMP occurrence in ACMP patients; receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of B/A ratio, S100β, cTnI, and their combined detection for DEACMP occurrence in ACMP patients.

RESULTS: A total of 178 patients with moderate-to-severe ACMP were enrolled, including 91 in the moderate poisoning group and 87 in the severe poisoning group; 157 in the good prognosis group and 21 in the poor prognosis group. In terms of disease severity, compared with the moderate poisoning group, the severe poisoning group had faster pulse and respiratory rates upon admission, longer coma duration and time from poisoning to treatment, higher levels of blood glucose, CRP, Lac, and BUN, and lower Alb levels (all P<0.05). In addition, the B/A ratio, S100β, and cTnI levels in the severe poisoning group were all higher than those in the moderate poisoning group at admission and 3 days after admission (all P<0.05). Compared with admission, the B/A ratio increased and the cTnI level decreased in the moderate poisoning group at 3 days after admission (both P<0.05), while S100β showed no significant change. In the severe poisoning group, there was no statistically significant difference in the B/A ratio, S100β, and cTnI levels at 3 days after admission compared to those at admission. In terms of prognosis, compared with the good prognosis group, the poor prognosis group had longer coma duration and time from poisoning to treatment at admission, a higher proportion of severe poisoning patients, higher levels of blood glucose, CRP, Lac, and BUN, and lower Alb levels (all P<0.05). In addition, the B/A ratio, S100β, and cTnI levels at admission and 3 days after admission were higher in the poor prognosis group than in the good prognosis group (all P<0.05). Correlation analysis showed that the B/A ratio, S100β, and cTnI levels at admission and 3 days after admission were correlated with the severity of ACMP and the occurrence of DEACMP (both P<0.05). Stepwise logistic regression analysis showed that the elevated B/A ratio [at admission: odds ratio (OR)=1.272, 95% confidence interval (95%CI)=1.028-1.573; on admission day 3: OR=1.170, 95%CI was 0.947-1.463], S100β (on admission: OR=1.065, 95%CI was 1.007-1.127; on admission day 3: OR=1.112, 95%CI was 1.060-1.165), and cTnI (on admission: OR=1.358, 95%CI was 1.055-1.748; on admission day 3: OR=1.201, 95%CI was 1.008-1.432) at admission and 3 days after admission were all risk factors for DEACMP in patients with ACMP (all P<0.05). ROC curve analysis showed that the area under the curve (AUC) for the combined prediction of DEACMP occurrence using B/A ratio, S100β, and cTnI on admission and on admission day 3 were 0.872 and 0.904, respectively. The sensitivities were 95.2% and 85.7%, respectively, and the specificities were 68.8% and 80.3%, respectively. The combined prediction efficacy of the three markers on admission was superior to that of the degree of intoxication and individual detection of the three markers, and the combined prediction efficacy of the three markers on admission day 3 was superior to that of the degree of intoxication, coma duration, and individual prediction of the three markers. Furthermore, the combined detection of the three markers on admission day 3 had a superior predictive efficacy compared to that on admission (all P<0.05).

CONCLUSIONS: Patients with moderate to severe ACMP are at higher risk of developing DEACMP when their early circulating levels of the B/A ratio, S100β, and cTnI are elevated. Combined detection of these three biomarkers facilitates early screening for DEACMP, with the highest predictive value observed at 3 days after admission.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhu B, Zhu Q, Du Y, et al. [Correlation analysis of blood urea nitrogen/albumin ratio, central nervous system specific protein S100 and cardiac troponin I with severity assessment and prognosis in patients with moderate-to-severe acute carbon monoxide poisoning]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42427327. doi:10.3760/cma.j.cn121430-20260128-00060

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。